Titan Medical Inc (TMDIF)

[BigT82]

Costs are outlined in the final prospectus pal as well as the MD&A released today.

2021:
Q1-Q2: $14.5M
Q3: $5.5M
Q4: $15.4M

So, that’s $35.4M through end of 2021

2022:
Q1:$6M
Q2-Q4: $19M

So, that’s $25M through end of 2022, for a total of $60.4M through END of 2022

2023:
TBD

Now, I expect costs to go up Q3-Q4 2022 if they submit to FDA. So, let’s say another $10-$15M maybe, on the high side? Ok, now we’re at $75M, on the high side, through 2022.

Cash on hand currently, plus Feb offering and 2 MDT milestones gives us approximately $80-$83M, and that’s without counting any future warrant execution, and there’s a ton of it out there, more than enough to get through end of 2022 and into 2023 easily.

Further appreciation in our PPS should be expected, as we complete milestones and move closer towards FDA. I don’t want further dilution, but if we have to raise $20M when the stock is $10 per share, it’s not so bad...

So, take a breath folks. TMDI has never, ever, been better capitalized, staffed, strategic partnered with, strategic tension talks, etc for our future success.

Our patience is about to pay off big time, for many of us, it already has. So, proceed to scoop!

Giddy up!